Literature DB >> 2429596

An endoscopic method of tympanic membrane fluorescein angiography.

E L Applebaum, E C Deutsch.   

Abstract

Fluorescein angiography is a recently developed method of studying the tympanic membrane's dynamic vasculature. Our preliminary studies using an ophthalmic fundus camera and aural speculum did not always permit visualization of the entire tympanic membrane, and the electronic flash unit used in our initial studies did not cycle fast enough to visualize effectively the rapid arterial phase of blood flow. In this report, we describe an endoscopic method of tympanic membrane fluorescein angiography that uses a continuous xenon light source. A representative angiogram from a normal subject is described. The mallear artery apparently is the major blood supply to the posterior half of the tympanic membrane, which is consistently better perfused than the anterior half. Branches from the annular ring of blood vessels supply the anterior half of the tympanic membrane. Preliminary studies of two temporalis fascia tympanoplasty patients indicate that the graft becomes revascularized 2 to 4 weeks after surgery and that posterior grafts may revascularize earlier than anterior grafts.

Entities:  

Mesh:

Year:  1986        PMID: 2429596     DOI: 10.1177/000348948609500501

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  14 in total

1.  Narrow band imaging endoscopy improves visualization of vessels of the perforated tympanic membrane.

Authors:  Adela Cordero Devesa; Miguel Vaca González; Franklin Mariño-Sánchez; Cecilia Pérez Martínez; Rubén Polo López; María Del Mar Medina González; Ignacio Cobeta Marco
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-06       Impact factor: 2.503

2.  A novel myringoplasty technique: the placement of a complementary graft descending from the scutum to support an anterosuperior perforation.

Authors:  Erdal Sakalli; Cengiz Celikyurt; Sultan Biskin; Selcuk Cem Erdurak
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-11       Impact factor: 2.503

3.  Assessment of the success rates of type 1 cartilage tympanoplasty in pediatric and adult patients.

Authors:  Zheng-Cai Lou; Zi-Han Lou
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-02-08       Impact factor: 2.503

4.  Endoscopic tympanoplasty with limited tympanomeatal flap elevation in pediatric cases: comparison of anatomic and audiological results of grafts.

Authors:  Alper Şen; Kadir Özdamar
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-11       Impact factor: 2.503

5.  Myringoplasty for anterior and subtotal perforations using KTP-532 laser.

Authors:  Imre Gerlinger; Gábor Ráth; István Szanyi; József Pytel
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-06-09       Impact factor: 2.503

6.  Comparison between endoscopic and microscopic butterfly cartilage graft inlay tympanoplasty: a systematic review and meta-analysis.

Authors:  José Faibes Lubianca Neto; Artur Koerig Schuster; Tales Antunes Fanzini; João Pedro Neves Lubianca; Lucas Rodrigues Mostardeiro; Roland Douglas Eavey
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-24       Impact factor: 2.503

7.  Half Disc Cartilage Tympanoplasty: A Newer Technique Versus Temporalis Fascia Tympanoplasty-Retrospective Analysis.

Authors:  Rajesh Raju George; E K Dhanya; Susan John; Irene Gee Varghese; Vishnu Narayanan; Shalini Kurian
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-09-01

8.  Comparitive Study on Impact of Dry (Rigid) Versus Wet (Soft) Graft on the Outcome of Type 1 Tympanoplasty.

Authors:  B H Shrikrishna; Meghana Poornima Ramesh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-01-02

9.  [Fluorescence of the middle ear].

Authors:  D Kleemann; S Nofz; A Schlottmann
Journal:  HNO       Date:  2008-02       Impact factor: 1.284

10.  Inferior flap tympanoplasty: a novel technique for anterior perforation closure.

Authors:  Haim Gavriel; Ephraim Eviatar
Journal:  Biomed Res Int       Date:  2013-08-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.